Åke Nilsson

Åke Nilsson

Professor emeritus

If you made any changes in Pure these will be visible here soon.

Personal profile


Research in physiological chemistry and since 1976 in medicine and gastroenetrology. Focus on digestion, absorption and transport of polar lipids, a field that has strong connections to the role of lipid signalling in the development of inflammatory bowel diisease. Clinically, treatment of inflammatory bowel disease and more recently of short bowel syndrome are main interests. Of particular interest is the finding that the enzyme alkaline sphingomyelinase, which was discovered, purified and cloned in our group, has antiinflammatory and anticancer effects, that counteract colon cancer. This effect has been confirmed both in clinical studies and recently in gene knoclout mice (together with prof Rui-Dong Duan)

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

UKÄ subject classification

  • Medical and Health Sciences


Dive into the research topics where Åke Nilsson is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or